For example universal coverage by a pneumococcal vaccine could not only save many of the estimated 800,000 children who die each year of pneumonia, it would also reduce by an estimated 47% the use of antimicrobials, counteracting the development of AMR.
Pereżempju kopertura universali b'vaċċin pnewmokokkali tista' mhux biss tiffranka ħafna mill-imwiet ta' 800,000 tifel u tifla li jmutu kull sena bil-pulmonite, iżda tkun tnaqqas ukoll bi stima ta' 47 % l-użu tal-antimikrobiċi, filwaqt li jiġi miġġieled l-iżvilupp tar-RAM.